Back to the full story2 sources · STAT+: Pharmalittle: We’re reading about Medicaid obesity-drug coverage, a Regenxbio gene therapy, and more◆ Analytics
STAT+: Pharmalittle: We’re reading about Medicaid obesity-drug coverage, a Regenxbio gene therapy, and more
Deterministic text analytics computed across all 2 sources. Frequency, entity overlap, and claim overlap — computed counts only. Nothing is rated true or false.
01
Frequency Analytics
The most common words and exact phrases across every report in this cluster. Computed counts only.
Top words
regenxbiotherapygenemedicaidconcernssafetytrialagainstathold
Top phrases
regenxbio gene therapyregenxbio genegene therapyregenxbio gene therapy trial againregenxbio gene therapy trialgene therapy trial againtherapy trial againgene therapy trialsafety concernstherapy trial
02
Entity Overlap
Names detected in the report text: which appear across multiple sources, and which only one source mentions.
Across multiple sources
- FDA · 2 sources
- Regenxbio · 2 sources
Unique to one source
- STAT · STAT
- Pharmalittle · STAT
- We’re · STAT
03
Claim Overlap
Near-identical sentences found in two or more reports, versus sentences that appear in only one. Text match only — nothing is rated true or false.
Repeated across sources
No sentence appeared in more than one source.
Appears once
- "President Trump’s pledge to make pricey weight loss drugs widely available for low-income Americans through Medicaid is not panning out Good morning, everyone, and welcome to another working week." · STAT
- "We hope the weekend respite was relaxing and invigorating because that oh-too-familiar routine of meetings, deadlines, and the like has returned with a vengeance." · STAT